GB001 in Adult Subjects With Moderate to Severe Asthma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A randomized, double‐blind, placebo‐controlled, dose‐ranging, multi‐center study to evaluate the efficacy and safety of GB001 when added to standard‐of care (SOC) asthma maintenance therapy in adults with moderate to severe asthma and an eosinophilic phenotype with respect to asthma worsening at the end of 24 weeks of treatment.
Epistemonikos ID: 8073b6b4c86edb5c845af921dc1d97b11f6d2141
First added on: May 21, 2024